Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
FIBROCELL SCIENCE, INC.
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
Over Five Years Ago
Previous Name(s)
- ISOLAGEN INC
- AMERICAN FINANCIAL HOLDING INC /DE
- AMERICAN FINANCIAL HOLDING INC /CO
Item 2 Issuer Principal Place of Business and Contact Information
405 EAGLEVIEW BOULEVARD
EXTON, PA 19341
Phone Number:
subscription required
Item 3. Related Persons
Name
DAVID PERNOCK
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
DECLAN DALY
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
KELVIN MOORE
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MARC MAZUR
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MARCUS SMITH
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JULIAN KIRK
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
BIOTECHNOLOGY
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
$1 - $1,000,000
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
10/09/2012
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
1500
Item 12. Sales Compensation
Recipient
BARCLAYS
Recipient CRD Number
19714
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
745 SEVENTH AVENUE
NEW YORK, NY 10019
States of Solicitation
Item 12. Sales Compensation
Recipient
MTS SECURITIES, LLC
Recipient CRD Number
104059
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
623 FIFTH AVENUE
14TH FLOOR
NEW YORK, NY 10022
States of Solicitation
Item 12. Sales Compensation
Recipient
JOHN CARRIS INVESTMENTS LLC
Recipient CRD Number
145767
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
40 WALL STREET
17TH FLOOR
NEW YORK, NY 10005
States of Solicitation
Item 13. Offering and Sales Amounts
Total Offering Amount
45000000
Total Amount Sold
45000000
Total Remaining to be Sold
0
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
114
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
2700000.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
FIBROCELL SCIENCE, INC.
Issuer Signature
DAVID PERNOCK
Signer Name
DAVID PERNOCK
Signer Title
CHIEF EXECUTIVE OFFICER
Signature Date
10/15/2012